CVE-2020-27256: SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A vulnerability
Sooil · SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A
Affected: SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A · Exploitation: unlikely (under 1%)
Not in CyberSIXT coverage yet: no article names this CVE. This page shows the public record.
Higher than 24% of scored CVEs
Not scored yet. The CVE record carries no CVSS score.
DescriptionCVE.org
In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a hard-coded physician PIN in the physician menu of the insulin pump allows attackers with physical access to change insulin therapy settings.
Affected products1
From the CVE record. A product or version that is not listed is unknown, not unaffected.
- SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-ADana Diabecare RS, AnyDana-i, AnyDana-A All versions prior…
On the Atlas
Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.
- Exploitation
- Unlikely (under 1%). EPSS under 1%, or no score yet.
- CISA KEV
- Not listed
- Public check
- No public nuclei template
- Vendor
- Sooil
- Published
- January 2021
CoverageNo articles yet
No CyberSIXT article names CVE-2020-27256 yet, so there is no coverage timeline, action brief or change log for it. Everything on this page comes from the public CVE record, CISA KEV, EPSS and the nuclei template index. Search the archive or see the CVEs in the news.